For participants who had AUD, obesity and type 2 diabetes, the use of GLP-1 medications was linked to "substantially ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

People taking weight loss and diabetes drugs like Ozempic can also regain weight if they stop treatment, hinting that the drugs don’t adjust the genetic changes (SN: 12/13/23). But perhaps other drugs ...

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...